Earnings History Data for Tarsus Pharmaceuticals, Inc. (TARS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutic candidates to address ophthalmic conditions. The company's product candidate consist TP-03 which is in clinical stage. Tarsus Pharmaceuticals Inc. is based in IRVINE, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
01-05-2025	AH		TARS	Tarsus Pharmaceuticals, Inc.	1,950	-0.64	-0.69	-1.01	Tarsus Pharmaceuticals, Inc. GAAP EPS of -$0.64, revenue of $78.3M [5/1/2025 4:46 PM]	47.46	-2.84 (-5.65%)	48.99	-1.31 (-2.60%)	20.08 - 57.28	829,377	730,000	6,274
Tarsus Pharmaceuticals, Inc. GAAP EPS of -$0.64, revenue of $78.3M [5/1/2025 4:46 PM] Tarsus Pharmaceuticals anticipates 85,000-90,000 XDEMVY bottles dispensed in Q2 2025 amid expanded DTC campaign [5/1/2025 9:37 PM] Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements [2025-05-01 04:05PM] Will Declining Medical Customers Affect Cigna's Q1 Earnings? [Apr-30-25 10:17AM] Wall Street Analysts See a 31.89% Upside in Tarsus Pharmaceuticals (TARS): Can the Stock Really Move This High? [Apr-30-25 09:55AM]
25-02-2025	PM		TARS	Tarsus Pharmaceuticals, Inc.	1,830	-0.60	-0.68	-1.31	Tarsus Pharmaceuticals GAAP EPS of -$0.60 beats by $0.07, revenue of $66.41M beats by $7.61M [2/25/2025 7:15 AM]	41.22	-4.32 (-9.50%)	49.00	3.46 (7.60%)	20.08 - 57.28	1,610,941	510,000	16,718
Tarsus Pharmaceuticals, Inc. Q4 2024 Earnings Preview [2/24/2025 12:38 PM] Tarsus Pharmaceuticals GAAP EPS of -$0.60 beats by $0.07, revenue of $66.41M beats by $7.61M [2/25/2025 7:15 AM] Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Achievements [2025-02-25 07:00AM] Tarsus Pharmaceuticals Inc (TARS) Q4 2024 Earnings Report Preview: What To Look For [2025-02-25 01:31AM] Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Tops Revenue Estimates [2025-02-25 08:40AM]
13-11-2024	AH		TARS	Tarsus Pharmaceuticals, Inc.	1,870	-0.61	-0.90	-1.28	Tarsus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.31, revenue of $48.1M beats by $4.92M [11/13/2024 4:18 PM]	46.67	0.16 (0.35%)	50.99	4.48 (9.64%)	15.60 - 52.99	980,317	930,000	2,191
Tarsus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.31, revenue of $48.1M beats by $4.92M [11/13/2024 4:18 PM] Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements [2024-11-13 04:05PM] Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors [2024-11-13 08:30AM]
08-08-2024	PM		TARS	Tarsus Pharmaceuticals, Inc.	874.27	-0.88	-0.98	-1.17	Tarsus Pharmaceuticals GAAP EPS of -$0.88 beats by $0.08, revenue of $40.81M beats by $8.76M [8/9/2024 3:31 AM]	26.77	3.16 (13.38%)	27.00	3.39 (14.36%)	12.57 - 42.50	2,472,166	920,000	5,493
Tarsus Pharmaceuticals GAAP EPS of -$0.88 beats by $0.08, revenue of $40.81M beats by $8.76M [8/9/2024 3:31 AM]
08-05-2024	AH		TARS	Tarsus Pharmaceuticals, Inc.	1,270	-1.01	-1.15	-0.88	Tarsus Pharmaceuticals GAAP EPS of -$1.01 beats by $0.18, revenue of $27.61M beats by $9.71M [5/8/2024 5:08 PM]	34.02	-3.33 (-8.92%)	42.61	5.26 (14.08%)	12.57 - 42.50	1,558,731	600,000	1,507
Tarsus Pharmaceuticals GAAP EPS of -$1.01 beats by $0.18, revenue of $27.61M beats by $9.71M [5/8/2024 5:08 PM]
27-02-2024	PM		TARS	Tarsus Pharmaceuticals, Inc.	1,050	-1.31	-1.37	-0.49	Tarsus Pharmaceuticals GAAP EPS of -$1.31 beats by $0.01, revenue of $13.08M beats by $7.16M [2/27/2024 6:09 AM]	39.17	6.01 (18.11%)	36.58	3.42 (10.31%)	11.33 - 39.77	2,043,208	800,000	17,040
Tarsus Pharmaceuticals GAAP EPS of -$1.31 beats by $0.01, revenue of $13.08M beats by $7.16M [2/27/2024 6:09 AM]
09-11-2023	AH		TARS	Tarsus Pharmaceuticals, Inc.	524.15	-1.28	-1.40	-0.84	Tarsus Pharmaceuticals GAAP EPS of -$1.28 beats by $0.11, revenue of $1.9M beats by $1.54M [11/9/2023 4:34 PM]	17.45	1.88 (12.07%)	17.00	1.43 (9.18%)	11.33 - 25.25	782,455	570,000	365,407
Tarsus Pharmaceuticals GAAP EPS of -$1.28 beats by $0.11, revenue of $1.9M beats by $1.54M [11/9/2023 4:34 PM] Tarsus files to sell $300M mixed securities shelf [11/9/2023 5:08 PM]
09-11-2022	PM		TARS	Tarsus Pharmaceuticals, Inc.	478.25	-0.84	-0.98	-0.76	Tarsus Pharmaceuticals GAAP EPS of -$0.84 beats by $0.13 [11/9/2022 8:47 AM]	17.69	-0.35 (-1.94%)	18.04	0.0 (0.00%)	10.80 - 28.25	72,523	110,000	1,031
Tarsus Pharmaceuticals GAAP EPS of -$0.84 beats by $0.13 [11/9/2022 8:47 AM] Tarsus Reports Third Quarter 2022 Financial Results and Recent Business Achievements [Nov-09-22 07:00AM]
14-03-2022	AH		TARS	Tarsus Pharmaceuticals	390.00	-0.72	-0.77	0.00	Tarsus Pharmaceuticals GAAP EPS of -$0.67 misses by $0.10, revenue of $57.03M beats by $7.96M [3/14/2022 5:52 PM]	16.85	0.85 (5.31%)	0.0	0.0 (0.00%)	14.41 - 42.50	19,932	26,201	0
Tarsus Pharmaceuticals GAAP EPS of -$0.67 misses by $0.10, revenue of $57.03M beats by $7.96M [3/14/2022 5:52 PM] Tarsus Pharmaceuticals, Inc. Reports Full-Year 2021 Financial Results and Recent Business Achievements [Mar-14-22 04:05PM]
09-11-2021	AH		TARS	Tarsus Pharmaceuticals	573.00	-0.76	-0.65	0.00	Tarsus Pharmaceuticals EPS misses by $0.42, misses on revenue [11/9/2021 5:09 PM]	27.79	0.21 (0.76%)	27.58	0.0 (0.00%)	19.67 - 63.69	18,672	30,000	100
Tarsus Pharmaceuticals EPS misses by $0.42, misses on revenue [11/9/2021 5:09 PM] Tarsus Pharmaceuticals, Inc. Reports Third Quarter 2021 Financial Results and Recent Business Achievements [Nov-09-21 04:05PM] Tarsus to Participate in the Virtual Jefferies London Healthcare Conference 2021 [Nov-10-21 04:30PM]
04-08-2021	AH		TARS	Tarsus Pharmaceuticals, Inc.	461.00	0.29	-0.44	0.00	Tarsus Pharmaceuticals EPS beats by $0.67, beats on revenue [8/4/2021 5:40 PM]	25.00	1.11 (4.65%)	23.89	0.0 (0.00%)	15.32 - 63.69	30,733	30,000	551
Tarsus Pharmaceuticals EPS beats by $0.67, beats on revenue [8/4/2021 5:40 PM] Tarsus Pharmaceuticals, Inc. Reports Second Quarter 2021 Financial Results and Provides Business and Clinical Updates [Aug-04-21 05:30PM]
11-05-2021	AH	After the close (May 11)	TARS	Tarsus Pharmaceuticals, Inc.	621.00	0.47	-0.64	0.00	Tarsus Pharmaceuticals EPS beats by $0.72 [5/11/2021 4:46 PM]	28.92	1.47 (5.36%)	0.0	0.0 (0.00%)	15.32 - 63.69	66,190	80,000	0
Tarsus Pharmaceuticals EPS beats by $0.72 [5/11/2021 4:46 PM] Tarsus Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business and Clinical Updates [May-11-21 04:05PM]